CNS disease models with human pluripotent stem cells in the CRISPR age

被引:14
|
作者
Muffat, Julien [1 ]
Li, Yun [1 ]
Jaenisch, Rudolf [1 ]
机构
[1] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA
关键词
ALZHEIMERS-DISEASE; CEREBRAL ORGANOIDS; HUMAN ES; GENERATION; NEURONS; OLIGODENDROCYTES; FIBROBLASTS; INSIGHTS; DYNAMICS; REVEALS;
D O I
10.1016/j.ceb.2016.10.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In vitro differentiation of human pluripotent stem cells provides a systematic platform to investigate the physiological development and function of the human nervous system, as well as the etiology and consequence when these processes go awry. Recent development in three-dimensional (3D) organotypic culture systems allows modeling of the complex structure formation of the human CNS, and the intricate interactions between various resident neuronal and glial cell types. Combined with an ever-expanding genome editing and regulation toolkit such as CRISPR/Cas9, it is now a possibility to study human neurological disease in the relevant molecular, cellular and anatomical context. In this article, we review recent progress in 3D neural culture and the implications for disease modeling.
引用
收藏
页码:96 / 103
页数:8
相关论文
共 50 条
  • [41] CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
    Chaterji, Somali
    Ahn, Eun Hyun
    Kim, Deok-Ho
    THERANOSTICS, 2017, 7 (18): : 4445 - 4469
  • [42] THE FEMALE AGE INFLUENCES THE EXPRESSION OF PLURIPOTENT STEM CELLS MARKERS IN HUMAN OVARIAN CELLS
    Todorov, Plamen
    Petrova, Nadya
    Mihova, Antoaneta
    Guenova, Margarita
    Arabadzhiev, Borislav
    Hristova, Elena
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2015, 68 (01): : 65 - 70
  • [43] Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells
    Molugu, Kaivalya
    Khajanchi, Namita
    Lazzarotto, Cicera R.
    Tsai, Shengdar Q.
    Saha, Krishanu
    CRISPR JOURNAL, 2023, 6 (05): : 473 - 485
  • [44] Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity
    Apati, Agota
    Varga, Nora
    Berecz, Tunde
    Erdei, Zsuzsa
    Homolya, Laszlo
    Sarkadi, Balazs
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (01) : 61 - 75
  • [45] GENERATION OF TROPHOBLAST MODELS FROM HUMAN PLURIPOTENT STEM CELLS: INSIGHTS INTO THE SIGNALING REQUIREMENTS OF HUMAN PLACENTAL STEM CELLS
    Karvas, Rowan
    PLACENTA, 2023, 140 : E19 - E19
  • [46] Efficient bi-allelic tagging in human induced pluripotent stem cells using CRISPR
    Ren, Xingjie
    Takagi, Maya Asami
    Shen, Yin
    STAR PROTOCOLS, 2023, 4 (01):
  • [47] MODELING AUTISM USING CRISPR/CAS9 AND HUMAN INDUCED PLURIPOTENT STEM CELLS
    Deneault, Eric
    Zaslaysky, Kirill
    Thompson, Tadeo
    Ellis, James
    Scherer, Stephen
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S161 - S161
  • [48] Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells
    Rossiaud, Lucille
    Fragner, Pascal
    Barbon, Elena
    Gardin, Antoine
    Benabides, Manon
    Pellier, Emilie
    Cosette, Jeremie
    El Kassar, Lina
    Giraud-Triboult, Karine
    Nissan, Xavier
    Ronzitti, Giuseppe
    Hoch, Lucile
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [49] Disease Models from Pluripotent Stem Cells Turning Back Time in Disease Pathogenesis?
    Lengerke, Claudia
    Daley, George Q.
    HEMATOPOIETIC STEM CELLS VII, 2009, 1176 : 191 - 196
  • [50] Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons
    Wu, Qianxin
    Wu, Junjing
    Karim, Kaiser
    Chen, Xi
    Wang, Tengyao
    Iwama, Sho
    Carobbio, Stefania
    Keen, Peter
    Vidal-Puig, Antonio
    Kotter, Mark R.
    Bassett, Andrew
    MOLECULAR CELL, 2023, 83 (07) : 1125 - +